Key Takeaways
- • Baillie Gifford US Growth Trust's board is urging shareholders to reject three board candidates nominated by Saba Capital, which holds approximately 29% of the trust, at the October 23 annual general meeting.
- • Saba Capital, led by activist hedge fund manager Boaz Weinstein, is attempting to gain board representation and potentially influence the trust's direction through its significant stake.
- • The existing board contends that installing Saba's nominees would compromise the trust's independence and potentially harm shareholder interests through conflicts of interest.
- • This proxy contest reflects broader tension between activist hedge fund investors seeking operational influence and established asset managers defending institutional independence and governance structures.
Summary
Baillie Gifford US Growth Trust faces a shareholder vote on October 23 that will determine whether hedge fund Saba Capital succeeds in placing three board nominees on its board of directors. Saba, controlled by prominent activist investor Boaz Weinstein, owns approximately 29% of the trust and has nominated candidates to reshape governance, triggering opposition from the incumbent board.
The trust's existing board has formally recommended that shareholders reject Saba's three nominees, arguing that their appointment would undermine board independence and create material conflicts of interest. The board's position reflects concerns that Saba's significant minority stake positions the hedge fund to advance its own investment agenda at the potential expense of other shareholders' interests.
This dispute underscores the strategic tension that emerges when large activist hedge fund positions intersect with closed-end fund governance. Saba's 29% holding grants considerable influence without triggering full control, creating the conditions for board-level contestation. The October 23 AGM will test whether existing shareholders align with management's independence arguments or support Saba's push for direct board influence.
The trust's existing board has formally recommended that shareholders reject Saba's three nominees, arguing that their appointment would undermine board independence and create material conflicts of interest. The board's position reflects concerns that Saba's significant minority stake positions the hedge fund to advance its own investment agenda at the potential expense of other shareholders' interests.
This dispute underscores the strategic tension that emerges when large activist hedge fund positions intersect with closed-end fund governance. Saba's 29% holding grants considerable influence without triggering full control, creating the conditions for board-level contestation. The October 23 AGM will test whether existing shareholders align with management's independence arguments or support Saba's push for direct board influence.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.